BMAL1 also increases sensitivity to paclitaxel in tongue squamous cell carcinoma by recruiting enhancer of zeste homolog 2 (EZH2) repressors to the telomerase reverse transcriptase (TERT) promoter to prohibit TERT transcription [24]. The gene discussed is EZH2; the disease is tongue squamous cell carcinoma.